Graf Akcie UTMD (Utah Medical Products, Inc.). Diskuze k akciím UTMD. Aktuální informace UTMD.

Základní informace o společnosti Utah Medical Products, Inc. (Akcie UTMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 328.34M
Hodnota podniku (EV) N/A
Tržby 46.057M
EBITDA N/A
Zisk 12.795M
Růst v tržbách Q/Q 43.44 %
Růst v tržbách Y/Y 4.64 %
P/E (Cena vůči ziskům) 25.65
Forward P/E N/A
EV/Sales 5.76
EV/EBITDA N/A
EV/EBIT 18.89
PEG N/A
Price/Sales 7.13
P/FCF 15.91
Price/Book 3.19
Účetní hodnota na akcii 28.20
Hotovost na akcii 14.15
FCF vůči ceně 6.29 %
Počet zaměstnanců 181
Tržba na zaměstnance 254.459k
Profit margin 25.60 %
Operating margin 35.87 %
Gross margin 60.57 %
EBIT margin 36.04 %
EBITDA margin 58.41 %
EPS - Zisk na akcii 3.51
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets 11.37 %
Return on equity 12.38 %
ROIC 12.50 %
ROCE 14.77 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA -6.91
Current ratio 15.93
Quick Ratio 14.55
Volatilita 2.38
Beta 0.58
RSI 45.55
Cílová cena analytiků 65
Známka akcie (dle analytiků) N/A
Insider ownership 6.86 %
Institutional ownership 74.03 %
Počet akcií 3.646M
Procento shortovaných akcií 1.51 %
Short ratio 5.62 %
Dividenda 1.14
Procentuální dividenda 1.26 %
Dividenda/Zisk 32.48 %
Obchodovaná od 1982
Země United States

Finanční výsledky akcie UTMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$46.904$41.998$41.414$39.298$40.157$41.278
Cost Of Goods Sold$17.438$15.692$15.019$15.608$15.972$16.295
Gross Profit$29.466$26.306$26.395$23.69$24.185$24.983
Research And Development Expenses$0.483$0.454$0.447$0.475$0.522$0.46
SG&A Expenses$11.351$7.155$6.937$7.028$8.012$8.321
Other Operating Income Or Expenses------
Operating Expenses$29.272$23.301$22.403$23.111$24.506$25.076
Operating Income$17.632$18.697$19.011$16.187$15.651$16.202
Total Non-Operating Income/Expense$0.252$0.762$0.071$0.235$-0.106$-0.39
Pre-Tax Income$17.884$19.459$19.082$16.422$15.545$15.812
Income Taxes$3.157$0.904$10.577$4.294$3.702$4.434
Income After Taxes$14.727$18.555$8.505$12.128$11.843$11.378
Other Income------
Income From Continuous Operations$14.727$18.555$8.505$12.128$11.843$11.378
Income From Discontinued Operations------
Net Income$14.727$18.555$8.505$12.128$11.843$11.378
EBITDA$24.514$21.653$21.784$19.02$18.798$19.558
EBIT$17.632$18.697$19.011$16.187$15.651$16.202
Basic Shares Outstanding444444
Shares Outstanding444444
Basic EPS$3.96$4.97$2.29$3.23$3.16$3.04
EPS - Earnings Per Share$3.94$4.95$2.28$3.22$3.14$3.02
# 2020 2019 2018 2017 2016 2015
Current Ratio15.918211.57859.315911.40778.08493.3079
Long-term Debt / Capital-----0.0148
Debt/Equity Ratio-----0.0754
Gross Margin62.821962.636363.734560.28360.226160.5238
Operating Margin37.591744.518845.904841.190438.974539.2509
EBIT Margin37.591744.518845.904841.190438.974539.2509
EBITDA Margin52.264251.557252.600648.399446.811347.3812
Pre-Tax Profit Margin38.128946.333246.076241.788438.710638.3061
Net Profit Margin31.398244.180720.536530.861629.491727.5643
Asset Turnover0.42720.4210.44650.51580.50720.5091
Inventory Turnover Ratio2.52252.89952.8643.43643.80653.3446
Receiveable Turnover9.891210.616311.430912.23868.80068.777
Days Sales In Receivables36.901634.381231.931129.823841.474641.5862
ROE - Return On Equity14.567820.850210.886817.514917.004117.625
Return On Tangible Equity25.873230.676518.414732.347438.557753.1906
ROA - Return On Assets13.414218.59829.170315.917914.95814.0338
ROI - Return On Investment14.567820.850210.886817.514917.004117.3633
Book Value Per Share27.160923.922620.994918.649118.567917.2241
Operating Cash Flow Per Share0.0701-0.0330.66680.1989-0.41830.8167
Free Cash Flow Per Share-0.1970.51711.1138-0.6288-0.17090.6124